Sanofi Vaccines Wins $13.1M Defense Contract for Injectable Influenza Vaccines

Sanofi Vaccines US Inc., Swiftwater, Pennsylvania, has been awarded a maximum $13,128,247 firm-fixed-price, indefinite-quantity contract for injectable influenza vaccines. This was a competitive acquisition with three responses received. This is a one-year contract with no option periods. The ordering period end date is Feb. 3, 2027. Using customers are Army, Navy, Air Force, Marine Corps and Coast Guard. Type of appropriation is fiscal 2026 through 2027 defense working capital funds. The contracting activity is Defense Logistics Agency Troop Support, Philadelphia, Pennsylvania (SPE2DP-26-D-0004).